Taysha Gene Therapies Inc

NASDAQ:TSHA  
2.77
-0.21 (-7.05%)
Earnings Announcements

Taysha Gene Therapies Reports Q4 Results

Published: 03/31/2022 12:03 GMT
Taysha Gene Therapies Inc (TSHA) - Q4 Loss per Share $1.32.
Qtrly Loss per Share $1.32.
Q4 Earnings per Share View $-1.26 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.99

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.92

More details on our Analysts Page.